1006-298X
2007 Issue 5
Mycophenolate mofetil versus intermittent cyclophosphamide pulse therapy in patients with crescentic IgA nephropathy
BAO Hao;TANG Zheng;YU Yusheng;WANG Jinquan;WANG Qingwen;CHEN Huiping;HU Weixin;LIU Zhihong;LI Leishi
BAO Hao;TANG Zheng;YU Yusheng;WANG Jinquan;WANG Qingwen;CHEN Huiping;HU Weixin;LIU Zhihong;LI Leishi
..............page:401-405,413
xing lang chuang xing shen yan he bing hu xi kun nan ka xue
jie fang jun shen zang bing yan jiu suo xue shu wei yuan hui
jie fang jun shen zang bing yan jiu suo xue shu wei yuan hui
..............page:494-499
xian wei lian jie dan bai shen xiao qiu bing
zeng cai hong ; liu zhi hong ; zheng chun xia ; chen hui ping ; li lei shi
zeng cai hong ; liu zhi hong ; zheng chun xia ; chen hui ping ; li lei shi
..............page:488-493
xi luo mo si zhuan huan zai shen yi zhi shou zhe zhong de ying yong
wen ji qiu ; ji shu ming ; yin guang
wen ji qiu ; ji shu ming ; yin guang
..............page:483-487
fu mo tou xi ji shu jin kuang
zhou yan ; yu yu sheng
zhou yan ; yu yu sheng
..............page:478-482
Relationship between blood concentration of mycophenolate mofetil and adverse drug reaction(ADR) in lupusnephritis
XIE Honglang;HU Weixin;ZHANG Haitao;BAO Hao;ZENG Caihong;ZHEN Chunxia;LIU Zhihong;LI Leishi
XIE Honglang;HU Weixin;ZHANG Haitao;BAO Hao;ZENG Caihong;ZHEN Chunxia;LIU Zhihong;LI Leishi
..............page:414-420
Monitoring of mycophenolic acid concentration for mycophenolate mofetil treatment in patients with glomerular diseases
ZHENG Chunxia;LIU Zhihong;QIN Weisong;ZENG Caihong;LI Leishi
ZHENG Chunxia;LIU Zhihong;QIN Weisong;ZENG Caihong;LI Leishi
..............page:406-413
xue jiang lv guo xi fu tou xi : yi zhong xin de xue ye jing hua ji shu
tao jing ; ji da zuo
tao jing ; ji da zuo
..............page:473-477
mei fen suan zuo xue yao nong du jian ce de lin chuang ying yong
zhan jin feng ; hu wei xin
zhan jin feng ; hu wei xin
..............page:468-472
xue hong su shen du xing de ji zhi
liu chun zuo ; hu wei xin
liu chun zuo ; hu wei xin
..............page:463-467
xian zhao zi zuo shen zang sun hai
wang jin quan ; tang zheng
wang jin quan ; tang zheng
..............page:458-462
zi ran sha shang xi bao ji qi yu zi shen mian yi xing ji bing de guan xi
bao hao ; zheng chun xia
bao hao ; zheng chun xia
..............page:453-457
shen xiao guan gong neng jian cha de lin chuang yi yi
wang wei ming
wang wei ming
..............page:451-452
zhong shi shen xiao guan gong neng jian cha zai shen xiao qiu ji bing zhen zhi zhong de ying yong
hu wei xin
hu wei xin
..............page:449-450
..............page:447-448
Proteasome inhibitor on proliferation and apoptosis of renal interstitial fibroblasts
ZHU Bingbing;JIN Yuanmeng;ZHANG Huidi;WANG Weiming;CHEN Nan
ZHU Bingbing;JIN Yuanmeng;ZHANG Huidi;WANG Weiming;CHEN Nan
..............page:441-446
Evaluation of CD20 cell infiltration and HLA-DR express on outcome of renal graft in patients with acute rejection
WEN Jiqiu;LI Leishi;CHEN Jinsong;ZHENG Chunxia;ZHANG Mingchao;SUN Qiquan;JI Shuming;CHENG Dongrui;LIU Zhihong
WEN Jiqiu;LI Leishi;CHEN Jinsong;ZHENG Chunxia;ZHANG Mingchao;SUN Qiquan;JI Shuming;CHENG Dongrui;LIU Zhihong
..............page:435-440
Mycophenolate mofetil for proliferative lupus nephritis: A meta-analysis of randomized controlled trials
QI Hualin;JIANG Wei;YAN Haidong
QI Hualin;JIANG Wei;YAN Haidong
..............page:426-434
Pharmacokinetics of mycophenolic acid in senile kidney transplant recipients and the clinical implications
MENG Fanhang;WANG Changxi;CHEN Lizhong;REN Bin;LI Shuxia;FEI Jiguang;DENG Suxiong;QIU Jiang;LI Jun;CHEN Guodong
MENG Fanhang;WANG Changxi;CHEN Lizhong;REN Bin;LI Shuxia;FEI Jiguang;DENG Suxiong;QIU Jiang;LI Jun;CHEN Guodong
..............page:421-425,446